Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Xeris Biopharma Holdings Inc’s stock clocked out at $4.02, down -2.19% from its previous closing price of $4.11. In other words, the price has decreased by -$2.19 from its previous closing price. On the day, 1.66 million shares were traded. XERS stock price reached its highest trading level at $4.1698 during the session, while it also had its lowest trading level at $3.95.
Ratios:
To gain a deeper understanding of XERS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.67.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.Craig Hallum initiated its Buy rating on August 28, 2023, with a $4.50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 20 ’25 when Hecht Beth sold 40,000 shares for $5.43 per share. The transaction valued at 217,244 led to the insider holds 1,353,510 shares of the business.
Hecht Beth bought 40,000 shares of XERS for $205,600 on Mar 20 ’25. On Aug 12 ’24, another insider, Schmid John P., who serves as the Director of the company, bought 4,515 shares for $2.25 each. As a result, the insider paid 10,147 and bolstered with 25,200 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 632695744 and an Enterprise Value of 818665344. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.05. Its current Enterprise Value per Revenue stands at 4.031 whereas that against EBITDA is -52.899.
Stock Price History:
The Beta on a monthly basis for XERS is 1.04, which has changed by 1.2584269 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $6.07, while it has fallen to a 52-week low of $1.69. The 50-Day Moving Average of the stock is -8.93%, while the 200-Day Moving Average is calculated to be 20.10%.
Shares Statistics:
It appears that XERS traded 2.97M shares on average per day over the past three months and 2893370 shares per day over the past ten days. A total of 149.43M shares are outstanding, with a floating share count of 141.94M. Insiders hold about 7.80% of the company’s shares, while institutions hold 42.82% stake in the company. Shares short for XERS as of 1743379200 were 17038478 with a Short Ratio of 5.74, compared to 1740700800 on 10633524. Therefore, it implies a Short% of Shares Outstanding of 17038478 and a Short% of Float of 11.3299996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
